New SELECT trial analysis with semaglutide 2.4 mg showed a significant reduction in hospital admissions in adults with known heart disease and obesity or overweight ...Middle East

Results from Novo Nordisk, presented at ObesityWeek®, showed treatment with semaglutide injection 2.4 mg resulted in significant reductions in hospital admissions as well as overall time spent in the hospital1 Cardiovascular disease represents the leading cause of death globally,2 and...

Hence then, the article about new select trial analysis with semaglutide 2 4 mg showed a significant reduction in hospital admissions in adults with known heart disease and obesity or overweight was published today ( Sunday 03/11/2024 - 11:32 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New SELECT trial analysis with semaglutide 2.4 mg showed a significant reduction in hospital admissions in adults with known heart disease and obesity or overweight )

Also on site :

• Cozy Tuesday, tracking a dangerous heatwave this week
• Blackpink’s Jisoo to Receive Madame Figaro Rising Star Award at Canneseries
• Disgusting! Mamdani Hosts Columbia Hamas Superfan Mahmoud Khalil for Ramadan Meal at Gracie Mansion